Comparison of [(18)F]fluorodeoxyglucose and [(68)Ga]Gallium DOTA-TATE in patients with active giant cell arteritis

比较[(18)F]氟代脱氧葡萄糖和[(68)Ga]镓DOTA-TATE在活动性巨细胞动脉炎患者中的应用

阅读:1

Abstract

PURPOSE: [(18)F]Fluorodeoxyglucose (FDG) is widely used in PET/CT imaging to detect large vessel vasculitis in giant cell arteritis (GCA), but its performance is suboptimal in patients receiving glucocorticoids. We aimed to compare [(68)Ga]Ga-HA-DOTA-TATE, a somatostatin 2-analogue tracer, to [(18)F]FDG in a pilot study of patients with GCA. METHODS: Eight patients with active GCA were prospectively, sequentially scanned with both [(18)F]FDG PET/CT and [(68)Ga]Ga-HA-DOTA-TATE PET/CT imaging. Images were evaluated by 2 blinded nuclear medicine specialists. Tracer uptake was assessed in 8 vascular territories using SUVmax, and target-background ratios (TBR) were calculated using both right atrium (TBR(RA)) and liver mean (TBR(liver)). Mean SUVmax and TBR of individual vascular territories and index vessels were compared. RESULTS: The patient median age was 71.5 years (range 64-82), and 4 (50%) were women. Active vasculitis (≥ grade 2 visual uptake in large vessels) was present in 62.5% of [(18)F]FDG scans. [(18)F]FDG scans had higher RA background activity than [(68)Ga]Ga-HA-DOTA-TATE (mean RA SUVmean 1.88 vs. 0.36, p < 0.001), while [(68)Ga]Ga-HA-DOTA-TATE had a significantly higher liver uptake (mean liver SUVmean 7.54 vs. 2.39, p < 0.001). Vascular uptake (as measured by both SUVmax and TBR(liver)) was significantly higher in [(18)F]FDG than [(68)Ga]Ga-HA-DOTA-TATE scans in every vascular territory (p < = 0.05 for all comparisons), including index vessels (SUVmax 4.04 vs. 1.91, p = 0.01, TBR(liver) 1.73 vs. 0.27, p < 0.001). CONCLUSION: In this pilot study of patients with active GCA, the arterial uptake of [(68)Ga]Ga-HA-DOTA-TATE was lower and less conspicuous compared to [(18)F]FDG. While further evaluation in larger cohorts is needed, a clear advantage of [(68)Ga]Ga-HA-DOTA-TATE over [(18)F]FDG for detecting vascular inflammation in GCA was not identified. TRIAL REGISTRATION, CLINICALTRIALS.GOV: NCT03812302, registered 2019-01-18, URL: https://clinicaltrials.gov/search?cond=dotatate%20%26;term=giant%20cell%20arteritis .

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。